Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novamin, Refix, and Refix-k for Dental Hypersensitivity in Periodontal Patients
NCT04422184Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jul 2019
- Primary completion
- May 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of Sensodyne Repair & Protect, Dentalclean Daily Regenerator, potassium citrate in dentin hypersensitivity (DH), sponsored by Universidade de São Paulo. Started Jul 2019; status: completed.
02
Drugs
Sensodyne Repair & ProtectDentalclean Daily Regeneratorpotassium citrate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT04422184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04422184.